Importantly, we also demonstrate that treatment with RSPO1 increases the replication of adult human β cells, such results suggesting a possible previously unexplored application of RSPO1 or RSPO1-like compounds for the treatment of T1D patients. Here, RSPO1 is linked to type 1 diabetes mellitus.